Italy: Competition Issues in the Italian Market for Infant Formulae

Last Updated: 7 September 2005
Article by Gabriele Accardo

The Italian competition Authority (the "Authority") has recently completed two investigations into the infant formulae industry after having received complaints from consumers about excessive prices.

The first investigation dealt with the acquisition of Mellin Spa (controlled by the Italian food group STAR) by Koninklijke Numico N.V. ("NUMICO").The deal which the Authority believed capable of creating a collective dominant position in the infant formulae markets has been conditionally authorised.

The second investigation aims to ascertain whether there exists an agreement between infant formulae manufacturers to co-ordinate their commercial policies with the aim of distributing their products only through pharmacies, in order to help keep prices high. This investigation is pending.

Specific Characteristics Of The Infant Formulae Markets In Italy

Both the investigations relate to the same infant formulae markets: i) infant formulae ii) follow-on formulas and iii) special formulae (that is, those milks which are used in particular circumstances).

The Authority found that these markets are highly concentrated1 and with a high degree of price transparency2. These conditions are normally viewed with suspicion by competition Authorities.

Despite infant formulae being a homogeneous product, in terms of nutritive properties, consumers perceive it as a medicinal product and are not greatly influenced by price.

According to the Authority such perception is due to a number of factors. Demand is essentially driven by the advice given in hospitals and, in general, by paediatricians to parents. In this regard, the Authority notes that the companies do not need to make great efforts in promoting and advertising3 their products to final consumers. However, they do invest in promoting their products to paediatricians, as well as by providing free supplies of infant formulae to the hospitals, given the influence that such "channels" have on consumer choice. This perception may be strengthened by the fact that infant formulas are sold mainly through pharmacies (supermarket's sales account for less than 10%).

The above factors have been taken into account in both investigations.

The Numico / Mellin Merger4

The Authority has recently completed the in-depth investigation on the acquisition of MELLIN by NUMICO. The Authority has granted a conditional clearance on the basis that, if fully implemented, NUMICO's commitments would be able to eliminate the competition concerns resulting from the concentration.

The NUMICO's commitments are essentially aimed at increasing the presence of infant formulae in the modern distribution "outlets".

Under the Italian merger control rules, the Authority must examine proposed concentrations to ascertain whether they create or strengthen a dominant position on the domestic market with the effect of eliminating or restricting competition appreciably and on a lasting basis. If as a consequence of a concentration such negative effects should occur in the market, the Authority must either prohibit the concentration or authorize it laying down the necessary measures to prevent such consequences.

According to the Authority, without the commitments undertaken by NUMICO, the notified transaction would have otherwise produced structural changes by creating a collective dominant position in the infant formulae markets, with the effect of allowing the main infant formulae manufacturers to achieve a stable "collusive equilibrium" enabling them to keep higher prices in the market.

NUMICO's commitments include terminating the sale in Italy of its brand, Nutricia, sold through pharmacies in order to decrease NUMICO's presence in that channel, and starting to distribute its other two infant formulae brands, Milupa and Mellin, through the modern distribution (that is, supermarket). NUMICO will also decrease prices for these infant formulae and special milks.


Despite a conditional clearance being completely unexpected, what matters now is to see whether the commitments will be fully implemented and, most important, whether the desired effect will be effectively achieved.

However, it may be that the commitments undertaken by NUMICO to increase the distribution of infant formulae in the modern distribution and to decrease prices for some of them will be followed by other infant formulae manufactures. Therefore it is reasonable to expect the increase of the distribution of baby and infant formulae in the modern distribution (supermarkets).

The real issue is, however, whether this will be followed by a consistent decrease of prices, which are, in some cases, double those in other countries. Price decreases may be achieved either autonomously by the infant formulae manufacturers if they should decide to compete effectively on the prices and the quality of their products or, secondly, as a result of the competitive dynamics which the commitments in the present decision may prompt, for example with the increased buyer power of the supermarkets.

The Investigation Into Possible Price Collusion

At its meeting on 8 July 2004, the Italian Authority resolved to commence an investigation5 into several infant formulae manufacturers6 with the purpose of ascertaining whether there exists an agreement between them to restrict competition in breach of Article 81 EC.

Article 81 EC prohibits agreements and concerted practices which may affect trade between Member States and which have as their object or effect the prevention, restriction or distortion of competition within the common market.

The current investigation is a similar to one which the Authority completed in 2000 with the conclusion that an anti-competitive agreement had been established between the principal manufacturers (Nestlé Italiana, Heinz Italia-Plasmon, Nutricia, Milupa, Humana and Abbott) to prevent infant formulae from being sold through the main supermarket and chain stores, and to ensure that their products would only be sold through pharmacies, in order to maintain high prices. At that time the Authority imposed fines totalling some 6 billion lire (approximately E3 million), which amounted to about three per cent of the turnover generated in the infant and special milk markets by the companies concerned.

Like the previous investigation the starting point of the new investigation was once again the difference in consumer prices between Italy and other Member States. The investigation has shown, in fact, an average price difference of about 150%. Considerable price differences were also observed in Italy in regard to a same product depending on the channel. Furthermore, the investigation has shown an average price increase of 13% between 2001 and 2003 (with peaks of 20%).

The European Court of Justice has held that parallel conduct cannot be regarded as furnishing proof of concertation unless concertation constitutes the only plausible explanation for such conduct. However, it is necessary to bear in mind that, although Article 81 EC of the Treaty prohibits any form of collusion which distorts competition, it does not deprive economic operators of the right to adapt themselves intelligently to the existing and anticipated conduct of their competitors.

The Authority has observed that manufacturers centralise their production in one Member State before then putting their products on European markets under different brands7. This means that production costs of each manufacturer are the same regardless of the market where the products are ultimately sold. The Authority believes that such high price difference could not be either justified by production or marketing costs.

Parallel Investigations

This case is the first where the Authority has enlisted the co-operation of the Competition Authorities of the other Member States of the EU under the Community Regulation 1/2003 (which came into force on 1 May 2004). Investigations have been conducted simultaneously on the premises of the companies concerned not only in Italy, but also in France, Germany and Spain, in light of the fact that, despite the considerable price difference between Member States, there were no parallel imports from countries where prices were lower than in Italy.

Conclusion So Far Of The Authority

The Authority concluded its preliminary investigation by finding that "since there appears to be no economic justification for this, the fact that prices in Italy are considerably higher than those charged by the same companies of the same products in other European countries appears to be due solely to coordination between the commercial policies of the baby milk producers. In fact the conduct at issue is based on the partitioning of the markets as well as on barriers to the imports, having thus the effect to determine higher prices in the Italian market".

The investigation is still pending. It seems that the parallel investigations did not provide the Italian competition Authority with the smoking guns, that is, the proof that an express agreement existed.


1. In particular, five companies (Plasmon/Heinz, Nestlé, Humana, Mellin and Numico) account for 95% of the supply in the infant milks and follow on formulae markets, whereas four manufacturers account for 90% of the special formulae supply.

2. In fact, recommended retail prices are distributed by manufacturers and are accordingly applied by pharmacists. Such price list is also accessible via an online database.

3. In fact, the Ministry Decree No 500 of 1994 (and more recently the Ministry Decree No 46 of 2005) prohibits any form of advertising in regard to infant formulae.

4. Italian Competition Authority's decision, "C6941 - Koninklijke Numico / Mellin" No 14390 of 15 June 2005, in Bulletin 23/2005.

5. Italian Competition Authority's decision to initiate the investigation "I623 - Prezzi del latte per l'infanzia", No 13350 of 8 July 2004, in Bulletin 28/2004.

6. Nestlé Italiana S.p.A., Nutricia S.p.A., Milupa S.p.A., Nutricia Italia S.p.A., Plasmon Dietetici Alimentari S.r.l., Heinz Italia S.r.l., Humana Italia S.p.A., Star S.p.A., Mellin S.p.A., Abbott S.p.A., Milte Italia S.p.A., Chiesi Farmaceutici S.p.A., Dicofarm S.p.A., Bristol-Myers Squibb S.r.l. and Syrio Pharma S.p.A..

7. NUMICO, for instance, produces in Holland its baby milk for the whole Europe.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.